| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/10/2002 | WO2001000877A3 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 05/10/2002 | WO2000078968A3 Nucleotide sequences of moraxella catarrhalis genome |
| 05/10/2002 | WO2000073507A3 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/10/2002 | WO2000073349A9 Dr4 antibodies and uses thereof |
| 05/10/2002 | WO2000067761A8 Compositions and methods for identifying antigens which elicit an immune response |
| 05/10/2002 | WO2000058339A3 50 human secreted proteins |
| 05/10/2002 | WO2000050639A3 Gene sequence variations with utility in determining the treatment of disease |
| 05/10/2002 | WO2000046407A3 Methods of utilizing the tt virus |
| 05/10/2002 | WO2000042208A8 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 05/10/2002 | CA2783639A1 Active variants of fgf with improved specificity |
| 05/10/2002 | CA2427952A1 Dna expression vectors |
| 05/10/2002 | CA2427850A1 Interferons, uses and compositions related thereto |
| 05/10/2002 | CA2427828A1 Novel human proteases and polynucleotides encoding the same |
| 05/10/2002 | CA2427802A1 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof |
| 05/10/2002 | CA2427800A1 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | CA2427763A1 Cell lines expressing a mch receptor |
| 05/10/2002 | CA2427747A1 Affinity maturation by competitive selection |
| 05/10/2002 | CA2427701A1 Human 7tm proteins and polynucleotides encoding the same |
| 05/10/2002 | CA2427624A1 Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the dna |
| 05/10/2002 | CA2427572A1 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | CA2427518A1 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | CA2427474A1 Method for the amplification and optional characterisation of nucleic acids |
| 05/10/2002 | CA2427436A1 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 05/10/2002 | CA2427316A1 Herbicide-tolerant plants through bypassing metabolic pathway |
| 05/10/2002 | CA2427267A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 05/10/2002 | CA2427257A1 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | CA2427223A1 Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1 |
| 05/10/2002 | CA2427214A1 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat |
| 05/10/2002 | CA2427163A1 Influenza virus vector for infection of dendritic cells |
| 05/10/2002 | CA2427031A1 Novel glucose dehydrogenase and method for producing the dehydrogenase |
| 05/10/2002 | CA2426658A1 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 05/10/2002 | CA2426121A1 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 05/10/2002 | CA2426047A1 Therapeutic oligonucleotides of reduced toxicity |
| 05/10/2002 | CA2425956A1 Novel glyphosate n-acetyltransferase (gat) genes |
| 05/10/2002 | CA2425583A1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 05/10/2002 | CA2424932A1 Cd36 as a heat shock protein receptor and uses thereof |
| 05/10/2002 | CA2395324A1 Expression potentiator for protein synthesis regulatory gene |
| 05/09/2002 | WO2002036153A1 Expression potentiator for protein synthesis regulatory gene |
| 05/09/2002 | US20020056153 Regulatory sequences for use in the control of expression of heterologous gene; for use as tools in genetic engineering |
| 05/09/2002 | US20020056152 Nucleotide sequences coding polypeptide; for use geenration of disease resistant plants |
| 05/09/2002 | US20020056151 Polypeptide for use as an insecticide; for generation of disease resistant plants |
| 05/09/2002 | US20020056150 Transgenic animal; for use in the detection, prevention and treatment of skin disorders |
| 05/09/2002 | US20020056149 Regenerating animal embryo; obtain cell, transfer diploid nucleus into cell, activate, recover viable infant |
| 05/09/2002 | US20020056147 Detecting genetically engineered rodents; obtain rodents, transform with expression vector, mate rodents, obtain sample tissue from infant, screen for genetic marker, presence of genetic marker indicates genetically engineered rodent |
| 05/09/2002 | US20020056146 Expression vector for use in generation of trangenic animals; for use in animal modeling of disease |
| 05/09/2002 | US20020056144 Transgenic animal models for cardiac hypertrophy and methods of use thereof (screening) |
| 05/09/2002 | US20020055769 Stent with smooth ends |
| 05/09/2002 | US20020055625 Members of TNF and TNFR families |
| 05/09/2002 | US20020055618 Methods and substances for preventing and treating autoimmune disease |
| 05/09/2002 | US20020055615 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 05/09/2002 | US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 05/09/2002 | US20020055492 Recognizes the extracellular domain of the human IFN-R and which has neutralizing capacity against the biological properties of human type I-IFN. |
| 05/09/2002 | US20020055482 Molecular constructs with a carcinoembryonic antigen (cea) transcriptional regulatory sequence |
| 05/09/2002 | US20020055480 SOX-9 gene and protein and use in the regeneration of bone or cartilage |
| 05/09/2002 | US20020055479 Treating type 2 diabetes, metabolic disorders, obesity and cancer. |
| 05/09/2002 | US20020055477 Immunomodulatory formulations and methods for use thereof |
| 05/09/2002 | US20020055476 RAMPs are small proteins that transport calcitonin-receptor-like proteins to the plasma membrane; drug screening |
| 05/09/2002 | US20020055475 Cytidylyl(3'-->5')guanosine ammonium salt (CpG); reducing the immunostimulatory effect for antisense applications |
| 05/09/2002 | US20020055467 Truncated neublastin, of the glial cell-derived nerve growth factor (GDNF) subfamily; when dimerized, binds to a RET (a receptor tyrosine kinase) polypeptide |
| 05/09/2002 | US20020055189 Propagating microorganism; mix nutrient broth, inoculate with cells, infect with preferential viruss, recover viral particles |
| 05/09/2002 | US20020055183 Proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 05/09/2002 | US20020055174 Complex for transferring an anionic substance of interest into a cell |
| 05/09/2002 | US20020055173 Plasmids for use in expressing heterologous proteins on surface viral particle and for use in gene therapy |
| 05/09/2002 | US20020055172 Multiple promoter expression constructs and methods of use |
| 05/09/2002 | US20020055169 Method for expression of heterologous proteins in yeast |
| 05/09/2002 | US20020055168 Streptococcus suis vaccines and diagnostic tests |
| 05/09/2002 | US20020055165 Genetically engineered cell; for use a tool in the monitoring of heterologous protein and gene expression in a cell; for use as a tool to generate genome variation in cell |
| 05/09/2002 | US20020055163 Amino acid sequences of peptides that are encoded by genes within the human genome, the protease peptides; useful in the development of human therapeutics and diagnostic formulations |
| 05/09/2002 | US20020055161 57658, a novel human uridine kinase and uses thereof |
| 05/09/2002 | US20020055160 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/09/2002 | US20020055159 23680,a novel human aminotransferase and uses therefor |
| 05/09/2002 | US20020055158 Human tissue inhibitor of metalloproteinase-4 |
| 05/09/2002 | US20020055157 Nucleotide sequences coding polypeptide for use in the treatment of cell differentiation, proliferation and migratory defects |
| 05/09/2002 | US20020055154 Nucleotide sequences which code for the acp gene |
| 05/09/2002 | US20020055153 L-lysine-producing corynebacteria and process for the preparation of lysine |
| 05/09/2002 | US20020055148 Cloning method for DNA fragments using arbitrarily primed PCR |
| 05/09/2002 | US20020055146 Control of the expression of anchored genes using micron scale heaters |
| 05/09/2002 | US20020055144 Human hematopoietic-specific protein |
| 05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
| 05/09/2002 | US20020055141 Genetically engineered microorgaism for use as diagnostic tool |
| 05/09/2002 | US20020055140 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 05/09/2002 | US20020055138 Staphylococcal GTPase obg nucleotide sequence encoding Staphylococcal GTP-binding protein |
| 05/09/2002 | US20020055137 Methods for detecting nucleic acid molecules encoding flh2882, a GPCR showing homology to the 5HT family of receptors |
| 05/09/2002 | US20020055136 Soluble recombinant alpha beta adhesion receptor |
| 05/09/2002 | US20020055128 Measuring binding of a candidate compound to the polypeptide (or to the cells or membranes bearing the polypeptide) or a fusion protein by means of a label associated with candidate compound, measuring binding, testing signal generated |
| 05/09/2002 | US20020055125 A solid substrate having planar surface; a plurality of different protein-binding agents bound to the substrate, each comprises achoring segment stably bound to the substrate surface, a peptidomimetic protein binding segment, a linker |
| 05/09/2002 | US20020055118 Image-scanning a polyacrylamide gel film containing electrophoresed DNA bands, offset-printing on an object having fixed shape using scanned image data and applying a DNA solution onto the offset-printed DNA band image |
| 05/09/2002 | US20020055116 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample |
| 05/09/2002 | US20020055115 Nucleotide sequences coding for the Dep33 efflux protein |
| 05/09/2002 | US20020055114 Nucleotide sequences coding for the chrS protein |
| 05/09/2002 | US20020055113 2'-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands |
| 05/09/2002 | US20020055112 Denaturing and incubating nucleic acid fragments that have some sequences repeated to produce double and single stranded subsets |
| 05/09/2002 | US20020055110 Matrix screening method |
| 05/09/2002 | US20020055109 Single-stranded trap using a single-strand binding protein |
| 05/09/2002 | US20020055107 Cancer diagnosis method using cell growth inhibiting and cell differentiation specific SYG972 gene and genomic DNA and promoter thereof |
| 05/09/2002 | US20020055106 Method for generating hypermutable organisms |
| 05/09/2002 | US20020055105 Method to identify interface residue in biomolecular complex |
| 05/09/2002 | US20020055100 Labelled nucleotides incorporated stepwise in a nucleic acid molecule by primer extension |
| 05/09/2002 | US20020055097 Comparing the levels of transcription of RNA transcripts from cells of known normal tissue and suspected mutant or cancer cells |
| 05/09/2002 | US20020055096 Determining the loss of heterozygosity at chromosome 3p24 in tissue |